[
    [
        {
            "time": "2019-12-31",
            "original_text": "公告精选：沃森生物13价肺炎球菌多糖结合疫苗获批上市；宝能受让长安PSA 50%股权",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎球菌多糖结合疫苗",
                    "获批上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公告精选：沃森生物13价肺炎球菌多糖结合疫苗获批上市；宝能受让长安PSA 50%股权",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物收购上海泽润13.04%股权",
            "features": {
                "keywords": [
                    "沃森生物",
                    "上海泽润",
                    "股权收购"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物收购上海泽润13.04%股权",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "首个国产13价肺炎疫苗获批上市，挑战辉瑞“利润奶牛”",
            "features": {
                "keywords": [
                    "国产13价肺炎疫苗",
                    "获批上市",
                    "辉瑞"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首个国产13价肺炎疫苗获批上市，挑战辉瑞“利润奶牛”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "首个国产13价肺炎结合疫苗获批上市，价格低于进口疫苗，距正式接种还需3个月以上",
            "features": {
                "keywords": [
                    "国产13价肺炎结合疫苗",
                    "获批上市",
                    "价格优势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首个国产13价肺炎结合疫苗获批上市，价格低于进口疫苗，距正式接种还需3个月以上",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物：13价肺炎球菌多糖结合疫苗上市注册申请获批",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎球菌多糖结合疫苗",
                    "上市注册申请获批"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：13价肺炎球菌多糖结合疫苗上市注册申请获批",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物(300142.SZ)：中保嘉沃及一致行动人减持1537.44万股 持股比例降至5%以下 减持股份",
            "features": {
                "keywords": [
                    "沃森生物",
                    "中保嘉沃",
                    "减持股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：中保嘉沃及一致行动人减持1537.44万股 持股比例降至5%以下 减持股份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物：中保嘉沃不再是公司持股5%以上股东",
            "features": {
                "keywords": [
                    "沃森生物",
                    "中保嘉沃",
                    "持股5%以上股东"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：中保嘉沃不再是公司持股5%以上股东",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "全球第二款！中国自主研发十三价肺炎结合疫苗获批上市",
            "features": {
                "keywords": [
                    "十三价肺炎结合疫苗",
                    "自主研发",
                    "获批上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "全球第二款！中国自主研发十三价肺炎结合疫苗获批上市",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "供不应求，规模超千亿！疫苗产业链分析（附流感概念）",
            "features": {
                "keywords": [
                    "疫苗产业链",
                    "供不应求",
                    "规模超千亿"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "供不应求，规模超千亿！疫苗产业链分析（附流感概念）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "2019年12月疫苗批签发数据跟踪月报",
            "features": {
                "keywords": [
                    "疫苗批签发数据",
                    "跟踪月报"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2019年12月疫苗批签发数据跟踪月报",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "国产13价肺炎疫苗上市在即，或与辉瑞正面“单挑”",
            "features": {
                "keywords": [
                    "国产13价肺炎疫苗",
                    "辉瑞",
                    "正面竞争"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国产13价肺炎疫苗上市在即，或与辉瑞正面“单挑”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "医药行业深度报告：疫苗2020-丰收之年,高光时刻",
            "features": {
                "keywords": [
                    "医药行业",
                    "疫苗",
                    "2020-丰收之年"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业深度报告：疫苗2020-丰收之年,高光时刻",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "沃森生物(300142.SZ)拟斥5亿元参设健康产业投资基金",
            "features": {
                "keywords": [
                    "沃森生物",
                    "健康产业投资基金",
                    "5亿元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)拟斥5亿元参设健康产业投资基金",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]